The anti-cancer drug daunorubicin induced specific activation of nSMase-2 in the human breast cancer cell line MCF-7, leading to depletion of surface membrane SM and accumulation of intracellular Cer [90]. This evidence concerns the gene CBLN1 and breast carcinoma.